Mcleod Russel India cash flow

Latest FY26

Cash from operations: ₹53.3cr−26.4% on FY25
Capital spending: ₹14.6crNo figure a year before
Free cash flow: ₹38.7cr−46.5% on FY25
Cash from financing: −₹32.7cr−₹50.5 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	61.1	61.2	65.8	69.9
	—	147	226	203	201
	—	0.0	−2.4	0.0	0.0
	—	−0.7	—	−0.9	2.5
	—	−0.0	—	−0.1	0.0
	—	147	—	−1.5	−1.8
	—	0.0	—	0.0	0.0
	—	1.8	—	0.0	−1.5
	—	−13.6	−11.5	52.5	33.7
	—	7.4	8.1	−2.0	16.4
	—	18.4	—	0.0	0.0
	—	0.0	—	8.5	0.0
	—	9.2	—	23.5	8.8
	—	2.1	—	0.0	0.0
	—	2.5	9.1	−30.3	36.9
	—	0.0	—	64.6	45.1
	—	48.8	—	0.0	0.0
	—	6.7	—	0.0	882
	—	−21.2	—	7.4	19.4
Cash from operating activities
	−335	−373	—	−362	−1,093
	—	416	—	386	1,312
	—	42.8	—	24.4	219
	—	−2.7	—	−4.8	−4.0
	—	−13.3	13.5	−14.7	10.0
	—	53.3	72.4	34.3	205
Cash from investing activities
	—	14.6	—	18.6	54.7
	—	−0.6	—	1.4	7.7
	—	−3.8	—	0.0	0.0
	—	0.0	—	1.1	1.6
	—	0.0	—	67.7	0.0
	—	0.0	0.2	0.0	0.0
	—	2.7	0.0	4.8	4.0
	—	2.7	—	0.6	−0.0
	—	−13.5	−18.9	56.9	−41.4
Cash from financing activities
	—	16.2	0.0	76.8	126
	—	0.0	—	3.3	1.5
	—	16.6	40.3	19.6	47.1
	—	−32.7	−50.5	−99.7	−174
	—	7.1	—	−8.5	−11.1
	—	0.5	—	−0.1	−0.1
	—	7.5	3.0	−8.6	−11.2
	—	—	—	5.4	13.9
Reference items
	−3.9	−25.9	—	−108	93.4
	−0.3%	−2.2%	—	−9.5%	6.8%
	38.7	38.7	72.4	15.7	150
	—	−384	41.6	−69.5	—
	₹3.71	₹3.71	₹6.93	₹1.50	₹14.35
	11.90×	—	—	—	—
	—	−0.43×	—	−0.11×	−0.19×
	—	−13.3	13.5	−14.7	10.0
	—	16.6	40.3	19.6	47.1

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MCLEODRUSS₹44.14

Mcleod Russel India Limited

· FMCG & Retail

₹ CrorePeersJAYSREETEA GILLANDERS ROSSELLIND DTIL GANGESSECU NORBTEAEXP VINCOFE ANDREWYUMcap ₹461 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	69.9	65.8	61.2	61.1	—
+ Finance Costs	200.5	203.4	226.1	146.7	—
+ Interest Income	0.0	0.0	-2.4	0.0	—
+ Fair Value (Gains) / Losses	2.5	-0.9	—	-0.7	—
+ Unrealised FX (Gain) / Loss	0.0	-0.1	—	-0.0	—
+ Other Non-cash Items	-1.8	-1.5	—	147.0	—
+ Other — Cash Effects are Investing / Financing	0.0	0.0	—	0.0	—
+ Other Reconciling Items	-1.5	0.0	—	1.8	—
Changes in Working Capital
+ Inventories	33.7	52.5	-11.5	-13.6	—
+ Trade Receivables — Current	16.4	-2.0	8.1	7.4	—
+ Other Financial Assets — Current	0.0	0.0	—	18.4	—
+ Other Financial Assets — Non-current	0.0	8.5	—	0.0	—
+ Other Current Assets	8.8	23.5	—	9.2	—
+ Other Non-current Assets	0.0	0.0	—	2.1	—
+ Trade Payables — Current	36.9	-30.3	9.1	2.5	—
+ Other Financial Liabilities — Non-current	45.1	64.6	—	0.0	—
+ Other Current Liabilities	0.0	0.0	—	48.8	—
+ Provisions — Current	881.9	0.0	—	6.7	—
+ Provisions — Non-current	19.4	7.4	—	-21.2	—
Cash from Operating Activities
Profit Before Tax (per I/S)	-1,093.4	-361.6	—	-373.3	-335.0
+ Total Adjustments (incl. Working Capital)	1,311.9	385.9	—	416.1	—
Cash from Operations (pre-tax)	218.5	24.4	—	42.8	—
+ Interest Received — Operating	-4.0	-4.8	—	-2.7	—
+ Income Taxes Paid	10.0	-14.7	13.5	-13.3	—
Cash from Operating Activities	204.5	34.3	72.4	53.3	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	54.7	18.6	—	14.6	—
+ Disp of Fixed Assets	7.7	1.4	—	-0.6	—
+ Disp of Investment Property	0.0	0.0	—	-3.8	—
+ Disp of Biological Assets	1.6	1.1	—	0.0	—
+ Disp of Subsidiaries / Businesses (net)	0.0	67.7	—	0.0	—
+ Dividends Received — Investing	0.0	0.0	0.2	0.0	—
+ Interest Received — Investing	4.0	4.8	0.0	2.7	—
+ Other Inflows / (Outflows) — Investing	-0.0	0.6	—	2.7	—
Cash from Investing Activities	-41.4	56.9	-18.9	-13.5	—
Cash from Financing Activities
+ Repayment of Borrowings	125.6	76.8	0.0	16.2	—
+ Payment of Lease Liabilities	1.5	3.3	—	0.0	—
+ Interest Paid	47.1	19.6	40.3	16.6	—
Cash from Financing Activities	-174.2	-99.7	-50.5	-32.7	—
Net Changes in Cash (pre-FX)	-11.1	-8.5	—	7.1	—
+ Effect of FX Rate Changes on Cash	-0.1	-0.1	—	0.5	—
Net Changes in Cash	-11.2	-8.6	3.0	7.5	—
Closing Cash	13.9	5.4	—	—	—
Reference Items
EBITDA	93.4	-108.1	—	-25.9	-3.9
EBITDA Margin %	6.82	-9.52	—	-2.24	-0.33
Free Cash Flow (CFO − Capex)	149.9	15.7	72.4	38.7	38.7
Free Cash Flow to Equity	—	-69.5	41.6	-384.0	—
Free Cash Flow per Basic Share	14.35	1.50	6.93	3.71	3.71
Price to Free Cash Flow	—	—	—	—	11.90
Cash Flow to Net Income	-0.19	-0.11	—	-0.43	—
Cash Paid for Taxes	10.0	-14.7	13.5	-13.3	—
Cash Paid for Interest	47.1	19.6	40.3	16.6	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.